financetom
Business
financetom
/
Business
/
Commerzbank on Overnight News
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Commerzbank on Overnight News
Jan 27, 2025 3:46 AM

06:27 AM EST, 01/27/2025 (MT Newswires) -- Commerzbank in its "European Sunrise" note of Monday highlighted:

Markets: United States Treasuries remain supported in Asia as China AI startup weighs on U.S. stock futures and Asian stocks are mixed. DXY recovers with EUR falling to $1.046. Oil and gold on the back foot.

Trump: The U.S. won't impose tariffs and sanctions as Colombia accepts the landing of all deported Colombians after U.S. President Donald Trump threatened to impose step-up tariffs of 25% and 50% on all imports. Trump to address Congress on March 4.

U.S.: New York Fed gross domestic product Nowcast remains unchanged at 2.56% for Q4 and 3% for Q1. St. Louis Fed model sees Q4 little changed at 2.38%. Official Q4 data due on Thursday with consensus at 2.7%.

NATO plans to share classified capability targets with the defense industry and the European Union to increase production, in what Secretary General Mark Rutte calls a "shift to a wartime mindset".

==EUROPE:

Germany: Center-right CDU leader Friedrich Merz is willing to accept far-right's AfD votes when submitting tougher migration proposals to Bundestag this week. AfD's leader Alice Weidel writes "the firewall has fallen!", center-left SPD speaks of "breaking of the dam." Green Party chancellor candidate and Economy Minister Robert Habeck warns of an Austria-style right-wing wave.

Ratings: Fitch affirms Netherlands at AAA/stable. DBRS confirms Belgium at AA/stable, Scope affirms Belgium at AA-/negative. Moody's raises Argentina for the first time in five years to Caa3.

United Kingdom banks urge the Bank of England to dilute its plans for handling failing lenders, arguing that it goes beyond equivalent rules in the U.S. or the E.U.

==ASIA:

China: Official PMIs disappoint with manufacturing falling 1pt to 49.1 and non-manufacturing falling 2pts to 50.2 while the consensus was for unchanged readings.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
AbbVie Says Phase 3 Trial of Upadacitinib in Alopecia Areata Meets Endpoints
AbbVie Says Phase 3 Trial of Upadacitinib in Alopecia Areata Meets Endpoints
Jul 30, 2025
10:01 AM EDT, 07/30/2025 (MT Newswires) -- AbbVie ( ABBV ) said Wednesday that one of two phase 3 pivotal studies of upadacitinib in adult and adolescent patients with severe alopecia areata met its primary endpoint of more scalp hair coverage and key secondary endpoints of improvements in eyebrows and eyelashes. The company said 44.6% and 54.3% of the patients...
Oracle Unusual Options Activity
Oracle Unusual Options Activity
Jul 30, 2025
Whales with a lot of money to spend have taken a noticeably bullish stance on Oracle. Looking at options history for Oracle we detected 10 trades. If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened trades with bullish expectations and 30% with bearish. From the overall spotted trades, 2 are...
Teva Pharm CEO says drugs sector facing 'big ambiguity' over US tariffs
Teva Pharm CEO says drugs sector facing 'big ambiguity' over US tariffs
Jul 30, 2025
JERUSALEM, July 30 (Reuters) - The CEO of Israel's Teva Pharmaceutical Industries said on Wednesday there was big ambiguity and so many unanswered questions in the drugs sector regarding potential U.S. tariffs, but the company was positioned for minimal impact. Richard Francis said 70% of Teva's generics business was outside of the United States while most of its branded drugs...
Copyright 2023-2025 - www.financetom.com All Rights Reserved